Compare TEF & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TEF | DXCM |
|---|---|---|
| Founded | 1924 | 1999 |
| Country | Spain | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medical/Dental Instruments |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.3B | 25.9B |
| IPO Year | 1987 | 2005 |
| Metric | TEF | DXCM |
|---|---|---|
| Price | $4.27 | $66.84 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 21 |
| Target Price | N/A | ★ $87.90 |
| AVG Volume (30 Days) | 1.1M | ★ 5.3M |
| Earning Date | 11-04-2025 | 10-30-2025 |
| Dividend Yield | ★ 5.52% | N/A |
| EPS Growth | N/A | ★ 7.75 |
| EPS | N/A | ★ 1.80 |
| Revenue | ★ $48,832,570,697.00 | $4,515,900,000.00 |
| Revenue This Year | N/A | $17.41 |
| Revenue Next Year | $0.09 | $12.78 |
| P/E Ratio | ★ N/A | $37.27 |
| Revenue Growth | 2.59 | ★ 14.21 |
| 52 Week Low | $3.89 | $54.11 |
| 52 Week High | $5.72 | $93.25 |
| Indicator | TEF | DXCM |
|---|---|---|
| Relative Strength Index (RSI) | 45.96 | 60.62 |
| Support Level | $4.13 | $64.00 |
| Resistance Level | $4.30 | $69.77 |
| Average True Range (ATR) | 0.05 | 1.96 |
| MACD | 0.04 | 0.78 |
| Stochastic Oscillator | 76.49 | 72.06 |
Telefonica is a telecom operator with presence in Spain (where it is the incumbent operator), the UK, Germany, Brazil, and Latin American countries. The company derives more than 30% of its revenue from Spain, close to 20% from Germany, and 20% from Brazil. Its UK operations are held through a joint venture with Virgin Media. For several years Telefonica has been simplifying its corporate structure by selling noncore assets.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.